Chemoinformaics analysis of N-(tert-butyl)-2-cyanoacetamide
| Molecular Weight | 140.186 | nRot | 1 |
| Heavy Atom Molecular Weight | 128.09 | nRig | 2 |
| Exact Molecular Weight | 140.095 | nRing | 0 |
| Solubility: LogS | -1.303 | nHRing | 0 |
| Solubility: LogP | 0.447 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.6935 |
| nHD | 1 | BPOL | 14.0465 |
| QED | 0.586 |
| Synth | 2.504 |
| Natural Product Likeliness | -1.718 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.009 |
| CACO-2 | -4.525 |
| MDCK | 0.0000952 |
| BBB | 0.995 |
| PPB | 0.438433 |
| VDSS | 0.945 |
| FU | 0.640745 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.313 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.085 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.167 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.126 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.412 |
| CL | 5.12 |
| T12 | 0.893 |
| hERG | 0.007 |
| Ames | 0.008 |
| ROA | 0.436 |
| SkinSen | 0.914 |
| Carcinogencity | 0.52 |
| EI | 0.987 |
| Respiratory | 0.984 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.951454 |